Mikhail Michel 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Dec 2, 2021
Insider Transaction Report
Form 4
Mikhail Michel
Chief Regulatory Officer
Transactions
- Award
Stock Option
2021-11-15$0.00/sh+75,000$75→ 75,000 totalExercise: $1.37Exp: 2031-11-15→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.